Disclaimer: Copyright infringement not intended.

Context

• Covaxin gets WHO’s emergency use no.

About

• According to WHO, Covaxin has 78% efficacy against COVID-19 of any severity, 14 or more days after the second dose, and is extremely suitable for low- and middle-income countries due to its easy storage requirements.
• Covaxin vaccine was reviewed by the WHO’s Strategic Advisory Group of Experts on Immunization (SAGE).

Significance

• Validation by the WHO is a very significant step towards ensuring global access to India’s widely administered, safe and efficacious Covaxin.

https://epaper.thehindu.com/Home/ShareArticle?OrgId=GGH95F3RG.1&imageview=0

Download PDF